Skip to main content
Top
Published in: International Urology and Nephrology 12/2017

01-12-2017 | Urology - Original Paper

Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?

Authors: Eve Boakes, Deepak Batura

Published in: International Urology and Nephrology | Issue 12/2017

Login to get access

Abstract

Purpose

To analyse the incidence and management of emphysematous pyelonephritis (EPN) in North West London and examine factors that influence immediate and 6-month outcomes with the aim of guiding future management.

Methods

This work analyses EPN cases from the London North West Healthcare NHS Trust from October 2006 to July 2015 (population ≈ 850,000). Diagnosis and stage were confirmed by computed tomography (CT). Demographic, clinical, biochemical and microbiological characteristics were assessed. Treatment modalities were medical management, minimally invasive management (MIM) and surgical. Immediate and 6-month outcomes were analysed.

Results

Thirteen cases were identified (f = 8, m = 5) from 5525 CT scans. EPN occurred in patients with diabetes mellitus (n = 11, 84.6%), hypertension (n = 10, 76.9%) or urinary tract calculi (n = 7, 53.85%). Unilateral EPN occurred predominantly (n = 11, 84.6%); 46.1% (n = 6) were class 1 or 2 and 53.8% (n = 7) class 3 or 4. Escherichia coli was most commonly cultured (n = 5, 38.46%). All patients received antibiotics, and ten cases required MIM. Two patients had a delayed nephrectomy, both survived. Mortality was 15.4% (n = 2, grade 1 and 3a), both died acutely post-MIM, neither underwent emergency nephrectomy. At 6 months, eight patients had ongoing renal impairment. No specific poor prognostic factors were identifiable.

Conclusions

Patients with low-grade EPN may also have a high mortality rate. In the two cases who died, earlier consideration for nephrectomy may have been prudent. It may be beneficial to have a low threshold for prompt emergency nephrectomy in severe cases and where MIM treatment has failed. We suggest a management algorithm to guide clinicians and minimise mortality.
Literature
1.
go back to reference Huang JJ, Tseng CC (2000) Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 160(6):797–805CrossRefPubMed Huang JJ, Tseng CC (2000) Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 160(6):797–805CrossRefPubMed
2.
go back to reference Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, Lee SS, Liu YC (2001) Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect 34(2):125–130PubMed Tang HJ, Li CM, Yen MY, Chen YS, Wann SR, Lin HH, Lee SS, Liu YC (2001) Clinical characteristics of emphysematous pyelonephritis. J Microbiol Immunol Infect 34(2):125–130PubMed
3.
go back to reference Chuang YW, Chen CH, Cheng CH, Hung SW, Yu TM, Wu MJ, Shu KH (2007) Severe emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and antibiotics. Clin Nephrol 68(1):42–46CrossRefPubMed Chuang YW, Chen CH, Cheng CH, Hung SW, Yu TM, Wu MJ, Shu KH (2007) Severe emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and antibiotics. Clin Nephrol 68(1):42–46CrossRefPubMed
7.
go back to reference Kamaliah MD, Bhajan MA, Dzarr GA (2005) Emphysematous pyelonephritis caused by Candida infection. Southeast Asian J Trop Med Public Health 36(3):725–727PubMed Kamaliah MD, Bhajan MA, Dzarr GA (2005) Emphysematous pyelonephritis caused by Candida infection. Southeast Asian J Trop Med Public Health 36(3):725–727PubMed
8.
go back to reference Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY (1998) Predictors of outcome in emphysematous pyelonephritis. J Urol 159(2):369–373CrossRefPubMed Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY (1998) Predictors of outcome in emphysematous pyelonephritis. J Urol 159(2):369–373CrossRefPubMed
12.
14.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655CrossRefPubMed
16.
go back to reference Sharma M, Pathak S, Srivastava P (2013) Prevalence and antibiogram of extended spectrum β-lactamase (ESBL) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 7(10):2173–2177. doi:10.7860/JCDR/2013/6460.3462 PubMedPubMedCentral Sharma M, Pathak S, Srivastava P (2013) Prevalence and antibiogram of extended spectrum β-lactamase (ESBL) producing gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. J Clin Diagn Res 7(10):2173–2177. doi:10.​7860/​JCDR/​2013/​6460.​3462 PubMedPubMedCentral
17.
go back to reference Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B (2016) Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. J Clin Diagn Res 10(9):DC19–DC22. doi:10.7860/JCDR/2016/21260.8544 Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B (2016) Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. J Clin Diagn Res 10(9):DC19–DC22. doi:10.​7860/​JCDR/​2016/​21260.​8544
19.
go back to reference Gopal Rao G, Batura D, Batura N, Nielsen PB (2015) Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing enterobacteriaceae in a multiethnic community, in North West London. Infect Dis (Lond) 47(10):719–724. doi:10.3109/23744235.2015.1055588 CrossRef Gopal Rao G, Batura D, Batura N, Nielsen PB (2015) Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing enterobacteriaceae in a multiethnic community, in North West London. Infect Dis (Lond) 47(10):719–724. doi:10.​3109/​23744235.​2015.​1055588 CrossRef
22.
go back to reference Olvera-Posada D, Armengod-Fischer G, Vazquez-Lavista LG, Maldonado-Avila M, Rosas-Nava E, Manzanilla-Garcia H, Castillejos-Molina RA, Mendez-Probst CE, Sotomayor M, Feria-Bernal G, Rodriguez-Covarrubias F (2014) Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology 83(6):1280–1284. doi:10.1016/j.urology.2014.02.010 CrossRefPubMed Olvera-Posada D, Armengod-Fischer G, Vazquez-Lavista LG, Maldonado-Avila M, Rosas-Nava E, Manzanilla-Garcia H, Castillejos-Molina RA, Mendez-Probst CE, Sotomayor M, Feria-Bernal G, Rodriguez-Covarrubias F (2014) Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology 83(6):1280–1284. doi:10.​1016/​j.​urology.​2014.​02.​010 CrossRefPubMed
23.
go back to reference Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D (2009) Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 41(4):959–966. doi:10.1007/s11255-009-9552-y CrossRefPubMed Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D (2009) Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 41(4):959–966. doi:10.​1007/​s11255-009-9552-y CrossRefPubMed
Metadata
Title
Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?
Authors
Eve Boakes
Deepak Batura
Publication date
01-12-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 12/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1706-8

Other articles of this Issue 12/2017

International Urology and Nephrology 12/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.